Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Internal Medicine
Dr. Zeshaan A. Rasheed, MD
|
|
Give Review
Zeshaan Rasheed works in the field of Internal Medicine. He went to Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Zeshaan Rasheed is a published doctor. He has 19 papers published. The most current publication "Activation of liver x receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma." Dr. Zeshaan A. Rasheed accepts all Medicare patients.
Publications
- Activation of Liver x receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma.
- Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.
- DCLK1 Marks a Morphologically Distinct Subpopulation of Cells with Stem Cell Properties in Pre-invasive Pancreatic Cancer.
- Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic Cancer.
- Tumorigenic potential of circulating Prostate tumor cells.
- Mechanisms of resistance to camptothecins.
- A direct pancreatic Cancer xenograft model as a platform for Cancer stem cell therapeutic development.
- Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
- The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and Malignant human tissues and may function as a tumor suppressor.
- Isolation of stem cells from human pancreatic Cancer xenografts.
- Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic Cancer growth and progression in murine xenograft models.
- Biological and clinical relevance of stem cells in Pancreatic adenocarcinoma.
- Concise review: Emerging concepts in clinical targeting of Cancer stem cells.
- Tumor-initiating cells are rare in many human Tumors.
- A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic Cancer stem cells and results in long-term disease control in human pancreatic c...
- Prognostic significance of tumorigenic cells with mesenchymal features in Pancreatic adenocarcinoma.
- Mechanisms of resistance to topoisomerase I-targeting drugs.
- The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care of Delaware PPO
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Kaiser Permanente
- MedHealthInsurance
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Mount Sinai School of Medicine -
Rutgers Robert Wood Johnson Medical School
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1528127016 | |
| NPPES Provider LastName | RASHEED | |
| NPPES Provider FirstName | ZESHAAN | |
| NPPES Provider ZIPCode | 212311000 | |
| NPPES Provider State | MD | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 51.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528127016 |
| Last Name Of The Provider | RASHEED |
| First Name Of The Provider | ZESHAAN |
| View All |
Similar Doctors
|
|
Dr. Beth R. Marcus, MD |
|
|
Dr. Evan J. Lipson, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nadia Ijaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ivan M. Borrello, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Venkataramana K. Sidhaye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence A. Doyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronan J. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ben H. Park, MD |
|
|
Dr. Valerie Lee, MD |